Literature DB >> 29199964

A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.

E Nucera1, F Basta2, A Buonomo1, S Mezzacappa1, D P Margiotta2, R Antonelli Incalzi3, D Schiavino1.   

Abstract

Entities:  

Keywords:  Chronic urticarial; HUVS; Hypocomplementemic urticarial vasculitis syndrome; Lupus; Omalizumab

Mesh：

Substances：

Year:  2017        PMID： 29199964     DOI： 10.18176/jiaci.0191

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  5 in total

1.  Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.

Authors:  Kenji Ueki; Akihiro Tsuchimoto; Yuta Matsukuma; Kumiko Torisu; Kiichiro Fujisaki; Takehiro Torisu; Yuichi Yamada; Yoshinao Oda; Kosuke Masutani; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2019-10-04

Review 2.  Two decades with omalizumab: what we still have to learn.

Authors:  Cristoforo Incorvaia; Marina Mauro; Elena Makri; Gualtiero Leo; Erminia Ridolo
Journal:  Biologics       Date:  2018-10-26

Review 3.  Urticarial vasculitis.

Authors:  Stephanie L Gu; Joseph L Jorizzo
Journal:  Int J Womens Dermatol       Date:  2021-01-29

4.  Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab.

Authors:  Marianne de Brito; Gisela Huebner; DedeeF Murrell; Peter Bullpitt; Karin Hartmann
Journal:  Clin Transl Allergy       Date:  2018-09-21       Impact factor: 5.871

5.  Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis.

Authors:  Taoming Liu; Juan Bai; Shuni Ying; Sheng Li; Yunlei Pan; Deren Fang; Jianjun Qiao; Hong Fang
Journal:  J Asthma Allergy       Date:  2021-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.